Abstract:Idiopathic hypogonadotropic hypogonadism (IHH) or Kallmann syndrome (KS) consists of absent or incomplete pubertal development, low-normal serum levels of the gonadotropins follicles stimulating hormone (FSH) and luteinizing hormone (LH), the absence of a pituitary tumor, and symptoms associated with hypogonadism, include amenorrhea, infertility and osteroporosis. Notably, patients with KS or IHH do not experience hot flashes. The prevalence of IHH was approximately 1 in 50,000 females. Evaluation and therapy can usually be implemented on an outpatient basis. In either KS or IHH, restoring fertility is possible in patients who generally respond to treatment with pulsatile GnRH or gonadotropins. Our objectives are to investigate clinical features and ovulation induction in women with IHH or KS. Retrospective clinical study. A retrospective study for clinical features was conducted on 19 women with IHH and 9 women with KS. To compare the clinical parameters (serum FSH, LH, E2, PRL, T and uterus volume, ovarian volume and overall basic antral follicles) between them and 28 normal controls with regular menstruation. All patients were treated with hormone replacement. Ovulation induction with HMG was taken on 10 IHH patients and 3 KS patients who desired fertility after at least 3 cycles of hormone replacement. Clinical characteristics of IHH and Kallmann include primary or secondary amenorrhea, no or partial or incomplete sexual development, no hot flashes, normal karyotype. Serum FSH, LH and PRL level in IHH and KS patients were significantly lower than those of controls (P<0.01). Serum LH and FSH levels were low-normal. There were no differences in serum E2 and T levels between IHH and KS patients and controls. Mean uterine and ovarian volume and the number of overall basic antral follicles were significantly smaller or less in IHH and KS patients as compared with controls (P<0.01). Uterus became larger after hormone replacement treatment. Ovulation happened when ovulation induction with hMG in 10 IHH patients and 3 KS patients. Low dose step up and step down protocol was taken for ovulation induction. The total dose of hMG per cycle was significantly higher (60 amples/cycle) in a significantly longer treatment period in IHH and KS patients than in controls. Five IHH patients and one KS patient got clinical pregnant. Hormone replacement and ovulation induction with hMG are cost effective treatments for IHH or KS patients who desire fertility.

A Review of Kallmann Syndrome: Genetics, Pathophysiology, and Clinical Management

[Clinical and genetic features of Kallmann syndrome: an analysis of 5 cases].

Kallmann syndrome: Diagnostics and management

Approach to the patient with Kallmann syndrome

Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.

Oral contraceptives. Increased cancer risk found.

Glomerular filtration rate in cows estimated by a prediction formula.

Point mutations in KAL1 and the mitochondrial gene MT-tRNA cys synergize to produce Kallmann syndrome phenotype

Diagnosis and management of Kallmann syndrome

Klinefelter Syndrome: A Genetic Disorder Leading to Neuroendocrine Modifications and Psychopathological Vulnerabilities in Children—A Literature Review and Case Report

Flavor perception test: evaluation in patients with Kallmann syndrome

Ultramarathon trail running comparison of performance-matched men and women.

A novel heterozygous intron mutation in SEMA7A causing kallmann syndrome in a female

A novel heterozygous mutation of CHD7 gene in a Chinese patient with Kallmann syndrome: a case report

Communication of the diagnosis to Klinefelter subjects: an observational study on a key moment of the patient’s life

Clinical Features and Ovulation Induction in Women with Idiopathic Hypogonadotropic Hypogonadism or Kallmann Syndrome.

Mutations in CHD7, Encoding a Chromatin-Remodeling Protein, Cause Idiopathic Hypogonadotropic Hypogonadism and Kallmann Syndrome

The Clinical and Genetic Characteristics in Children with Idiopathic Hypogonadotropin Hypogonadism

Klinefelter syndrome: etiology and clinical considerations in male infertility†

Prevalence of pathogenic variants and digenic disease in patients diagnosed with normosmic hypogonadotropic hypogonadism/Kallmann Syndrome

Plasma Agmatine and Platelet Imidazoline Receptors in Depression a